Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection

Abstract

SARS-COV-2 has created one of the most massive pandemics in modern history. There is a rapid accumulation of data on its epidemiology, clinical course, diagnosis, management, and complications. One of the sequelae of COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) is pulmonary fibrosis. There is a dearth of accurate data on the prevalence of pulmonary fibrosis post-COVID-19. We report a patient who developed dyspnea secondary to pulmonary fibrosis after successful treatment of COVID-19 pneumonia.

Keywords

• Coronavirus infection 2019
• COVID-19
• Severe acute respiratory syndrome coronavirus 2
• SARS-CoV-2
• Acute respiratory distress syndrome
• ARDS